Similarly, a significant increase in the RBC expression of the URAT1 transporter was observed under all these conditions, while a significantly increased ABCA1 expression was only found when successfully managed patients or patients with disease-related complications were compared to control subjects or untreated T2DM patients (Table 3). Here, ABCA1 is linked to type 2 diabetes mellitus.